Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; the references it cites are not checked yet.

The role of IL-1 in the pathogenesis of heart disease

Open access
Bujak, Marcin, Frangogiannis, Nikolaos G. · 2009 · Archivum Immunologiae et Therapiae Experimentalis

Abstract

Interleukin (IL)-1 consists of two distinct ligands, IL-1alpha and IL-1beta, with indistinguishable biological activities that signal through the IL-1 type I receptor (IL-1RI). A naturally occurring IL-1 receptor antagonist (IL-1Ra) binds to IL-1RI without initiating signal transduction and prevents IL-1 signaling, competitively inhibiting IL-1-mediated responses. Emerging evidence suggests that the balance between IL-1 agonists and antagonists plays an essential role in a variety of cardiovascular conditions. IL-1 may play a role in atherothrombotic disease by promoting the formation of atheromatous lesions, enhancing vascular inflammation, and triggering plaque destabilization. Following myocardial infarction, IL-1 critically regulates the inflammatory response and is involved in the development of adverse remodeling by enhancing expression of matrix metalloproteinases. IL-1 signaling may also be an essential mediator in the pathogenesis of heart failure by suppressing cardiac contractility, promoting myocardial hypertrophy, and inducing cardiomyocyte apoptosis. The present review summarizes current available data showing the significant role of IL-1 signaling in heart disease and raising the possibility that IL-1 inhibitors (such as anakinra, a nonglycosylated recombinant human IL-1Ra) may be clinically useful agents in patients with certain cardiovascular conditions.

Overview

Integrity signals

Registry

Crossref · 10.1007/s00005-009-0024-y

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

The citation lists are queued

They are fetched later and appear here then.

References 123 · Cited by 307

Metadata

Authors
Bujak, M., & Frangogiannis, N. G.
Affiliations
Baylor College of Medicine (US)
Corresponding author
Frangogiannis, Nikolaos G.
Venue
Archivum Immunologiae et Therapiae Experimentalis
Published
2009-05-29
Volume
57
Issue
3
Pages
165-176
ISSN
  • 0004-069X (ISSN-L)
  • 1661-4917
OpenAlex
W2010216650
Cited by
307
References
123
Citations by year
2026: 9 · 2025: 12 · 2024: 15 · 2023: 14 · 2022: 20 · 2021: 12 · 2020: 23 · 2019: 22 · 2018: 27 · 2017: 26 · 2016: 17 · 2015: 24 · 2014: 16 · 2013: 22 · 2012: 28
FWCI
2.21
Type
journal article
Language
en
Open access
Licence
www.springer.com/tdm (tdm)
Locations
  • Archivum Immunologiae et Therapiae Experimentalis (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Heart, Lung, and Blood Institute (R01HL085440, R01HL076246)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
  • Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
Keywords
interleukin-1, IL-1α, IL-1β, interleukin-1 receptor antagonist, IL-1 receptor, atherothrombosis, plaque destabilization, vascular inflammation, myocardial infarction, cardiac remodeling, matrix metalloproteinases, heart failure, cardiac hypertrophy, cardiomyocyte apoptosis, anakinra, IL-1 inhibitors, cardiovascular disease
MeSH terms
Animals, Heart Diseases, Humans, Inflammation, Signal Transduction, Metalloproteases, Receptors, Interleukin-1 Type I, Interleukin-1alpha, Interleukin-1beta, Interleukin 1 Receptor Antagonist Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The role of IL-1 in the pathogenesis of heart disease. https://app.cochat.ai/papers/10.1007/s00005-009-0024-y
The paper
Bujak, M., & Frangogiannis, N. G. (2009). The role of IL-1 in the pathogenesis of heart disease. Archivum Immunologiae et Therapiae Experimentalis. https://doi.org/10.1007/s00005-009-0024-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.